CBB3001
CBB3001 is an inhibitor of LSD1/KDM1A. CBB3001 exerts its effect by inhibiting Histone Demethylase activity, with an IC50 of 21.25 μM. It downregulates the expression of pluripotency-related proteins and genes such as SOX2 and OCT4, and induces cell differentiation, growth arrest, and apoptosis. CBB3001 can be used for research on testicular germ cell tumors, teratomas, and embryonal carcinomas.
For research use only. We do not sell to patients.
- CAS No.: 1639358-50-1
- Formula: C19H27NO5
- Molecular Weight:349.43
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[2]|
KDM1/LSD1 |
SOX2 |
OCT4 |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| PA-1 | IC50 |
20 μM
|
Growth inhibition against human ovarian teratocarcinoma PA-1 cells.
Growth inhibition against human ovarian teratocarcinoma PA-1 cells.
|
30765888 |
| F9 | IC50 |
20 μM
|
Growth inhibition against mouse embryonal carcinoma F9 cells.
Growth inhibition against mouse embryonal carcinoma F9 cells.
|
30765888 |
In Vitro
CBB3001 (1-100 μM) potently inhibits the demethylase activity of purified recombinant GST-LSD1 protein in vitro, with an IC50 of 21.25 μM[2].
CBB3001 (20 μM; 16 h) inhibits LSD1 histone demethylase activity in human colorectal cancer HCT116 cells and human ovarian teratocarcinoma PA-1 cells, thereby increasing the levels of monomethylated and dimethylated H3K4, but does not affect the level of trimethylated H3K4[2].
CBB3001 (20-40 μM; 16-30 h) downregulates the expression of the pluripotent stem cell proteins SOX2 and OCT4 in human ovarian teratocarcinoma PA-1 cells and mouse embryonal carcinoma F9 cells[2].
CBB3001 (20 μM; 20 h) reduces EZH2 protein levels in wild-type mouse embryonic fibroblasts[4].
CBB3001 (10 h treatment) reduces the protein levels of mSWI/SNF complex subunits in CAGGCre-ER/LSD1fl/fl mouse embryonic fibroblasts (MEFs) within 10 h[5].
CBB3001 (1-40 μM; 12-30 h) selectively inhibits the growth of human ovarian teratocarcinoma PA-1 cells and mouse embryonal carcinoma F9 cells, but exerts no significant effect on the growth of human colorectal cancer HCT116 cells or mouse fibroblast NIH3T3 cells[2].
CBB3001 (20-40 μM) potently inhibits the growth of human ovarian teratocarcinoma (PA-1) cells and mouse embryonal carcinoma (F9) cells, with an IC50 of approximately 20 μM. It also reduces the expression of pluripotency markers and exerts no effect on non-pluripotent tumor cells[3].
CBB3001, a histone demethylase inhibitor, inhibits cell growth, downregulates pluripotency, and upregulates differentiation in testicular germ cell tumor cell lines[7].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:human colorectal carcinoma HCT116 cells, human ovarian teratocarcinoma PA-1 cells
-
Concentration:20 μM
-
Incubation Time:16 h
-
Result:Increased levels of mono-methylated H3K4 and di-methylated H3K4 in both HCT116 and PA-1 cells.
Left the level of trimethylated H3K4 unchanged in both HCT116 and PA-1 cells.
-
Cell Line:human ovarian teratocarcinoma PA-1 cells, human colorectal carcinoma HCT116 cells, mouse embryonic carcinoma F9 cells, mouse fibroblast NIH3T3 cells
-
Concentration:1, 5, 10, 20, 40 μM (PA-1 and HCT116 cells); 20, 40 μM (F9 and NIH3T3 cells)
-
Incubation Time:16 hours (PA-1 and HCT116 cells); 30 hours (F9 and NIH3T3 cells)
-
Result:Potently inhibited the growth of PA-1 cells at concentrations between 5-40 μM, with reduced relative cell percentages observed at each tested concentration.
Did not significantly affect the growth of HCT116 cells even at concentrations up to 40 μM.
Inhibited the growth of F9 cells at 20 and 40 μM.
Had no significant effect on NIH3T3 cell growth at 20 and 40 μM.
-
Cell Line:human ovarian teratocarcinoma PA-1 cells, mouse embryonic carcinoma F9 cells
-
Concentration:20, 40 μM (PA-1 cells); 40 μM (F9 cells)
-
Incubation Time:16 hours (PA-1 cells); 30 hours (F9 cells)
-
Result:Downregulated SOX2 and OCT4 protein levels in PA-1 cells compared to control-treated cells.
Downregulated SOX2 and OCT4 protein levels in F9 cells compared to control-treated cells.
-
Cell Line:human ovarian teratocarcinoma PA-1 cells
-
Concentration:20, 40 μM
-
Incubation Time:24 hours initial incubation, followed by 24 hours recovery in fresh medium
-
Result:Did not reverse growth inhibitory effects on PA-1 cells after removing the compound and allowing 24 hours of recovery in fresh medium.
Left reduced relative cell percentages remaining similar to levels immediately after treatment.
-
Cell Line:wild-type mouse embryonic fibroblasts (MEFs)
-
Concentration:20 μM
-
Incubation Time:20 h
-
Result:Reduced EZH2 protein level significantly.
Left KDM1A protein levels unchanged.
Chemical Information
-
CAS No. 1639358-50-1
-
Molecular Weight 349.43
-
Formula C19H27NO5
-
SMILES
N(C(OC(C)(C)C)=O)[C@H]1[C@@H](C1)C2=CC=C(OC(OC(C)(C)C)=O)C=C2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Totipotent stem cell culture
Totipotent stem cells are all the cells from the fertilized egg to the 32-cell stage of oogenesis, with unlimited potential for differentiation into cells of various tissues and organs and formation of complete individual.
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Human iPSC generation/reprogramming culture
Human iPSC reprogramming converts somatic cells into pluripotent cells by introducing defined transcription factors; classic human studies used OCT3/4, SOX2, KLF4, and c-MYC, or OCT4, SOX2, NANOG, and LIN28, and judged reprogramming by embryonic-stem-cell-like morphology, pluripotency-marker expression, normal karyotype, and differentiation into derivatives of the three germ layers. This protocol is framed around non-integrating reprogramming culture, with Sendai virus, episomal plasmids, or synthetic modified mRNA as literature-supported delivery options; Sendai virus is an RNA vector reported to avoid host-genome integration, episomal vectors can generate integration-free human iPSCs, and modified mRNA can reprogram human cells while avoiding genomic modification.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
iPSC cell differentiation
Induced pluripotent stem cells (iPSCs) are a type of cell that has similar properties to embryonic stem cells through somatic cell reprogramming.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)